Genetics of infectious and inflammatory diseases: Overlapping discoveries from association and exome-sequencing studies

Annual Review of Immunology

Volumn 35, Issue , 2017, Pages 1-30

  Langlais, David ^a,b   Fodil, Nassima ^a,b   Gros, Philippe ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Epigenetics; Genome sequencing; Genome wide association studies; Infections; Inflammation; Primary immunodeficiencies

Indexed keywords

VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNE DISEASE; CELIAC DISEASE; DENGUE; EPIGENETICS; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DATABASE; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; LEPROSY; MALARIA; MENINGITIS; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE; WHOLE EXOME SEQUENCING; ANIMAL; EXOME; GENETIC ASSOCIATION STUDY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HIGH THROUGHPUT SEQUENCING; IMMUNITY; IMMUNOLOGY; INFLAMMATION; RISK;

ANIMALS; AUTOIMMUNE DISEASES; EPIGENESIS, GENETIC; EXOME; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNITY; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; INFLAMMATION; RISK; VACCINES;

EID: 85018347765     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-051116-052442     Document Type: Review

References (178)

1. Newport MJ, Finan C. 2011. Genome-wide association studies and susceptibility to infectious diseases. Brief Funct. Genom. 10:98-107
2. Khor CC, Hibberd ML. 2012. Host-pathogen interactions revealed by human genome-wide surveys. Trends Genet. 28:233-43
3. Vannberg FO, Chapman SJ, Hill AV. 2011. Human genetic susceptibility to intracellular pathogens. Immunol. Rev. 240:105-16
4. Bongfen SE, Laroque A, Berghout J, Gros P. 2009. Genetic and genomic analyses of host-pathogen interactions in malaria. Trends Parasitol. 25:417-22
5. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, et al. 2002. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359:1311-12
6. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-62
7. Casanova JL, Abel L. 2013. The genetic theory of infectious diseases: a brief history and selected illustrations. Annu. Rev. Genom. Hum. Genet. 14:215-43
8. Chapman SJ, Hill AV. 2012. Human genetic susceptibility to infectious disease. Nat. Rev. Genet. 13:175-88
9. Picard C, Fischer A. 2014. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur. J. Immunol. 44:2854-61
10. Chou J, Ohsumi TK, Geha RS. 2012. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies. Curr. Opin. Allergy Clin. Immunol. 12:623-28
11. Casanova JL. 2015. Severe infectious diseases of childhood as monogenic inborn errors of immunity. PNAS 112:E7128-37
12. Casanova JL. 2015. Human genetic basis of interindividual variability in the course of infection. PNAS 112:E7118-27
13. Milner JD, Holland SM. 2013. The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat. Rev. Immunol. 13:635-48
14. Delogu LG, Deidda S, Delitala G, Manetti R. 2011. Infectious diseases and autoimmunity. J. Infect. Dev. Ctries 5:679-87
15. Karlsson EK, Kwiatkowski DP, Sabeti PC. 2014. Natural selection and infectious disease in human populations. Nat. Rev. Genet. 15:379-93
16. Abel L, Alcais A, Schurr E. 2014. The dissection of complex susceptibility to infectious disease: bacterial, viral and parasitic infections. Curr. Opin. Immunol. 30:72-78
17. Parkes M, Cortes A, van Heel DA, Brown MA. 2013. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14:661-73
18. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al. 2011. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43:246-52
19. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al. 2010. Genome-wide metaanalysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 42:1118-25
20. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119-24
21. Okada Y, Wu D, Trynka G, Raj T, Terao C, et al. 2014. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506:376-81
22. Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, et al. 2012. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44:1341-48
23. Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, et al. 2010. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat. Genet. 42:991-95
24. Int. Mult. Scler. Genet. Consort., Wellcome Trust Case Control Consort. 2, Sawcer S, Hellenthal G, Pirinen M, et al. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214-19
25. Int. Mult. Scler. Genet. Consort., Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, et al. 2013. Analysis of immune-related loci identifies 48 new susceptibility variants formultiple sclerosis. Nat. Genet. 45:1353-60
26. Bentham J, Morris DL, Cunninghame Graham DS, Pinder CL, Tombleson P, et al. 2015. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47:1457-64
27. Ellinghaus D, Jostins L, Spain SL, Cortes A, Bethune J, et al. 2016. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat. Genet. 48:510-18
28. Bentham J, Morris DL, Cunninghame Graham DS, Pinder CL, Tombleson P, et al. 2015. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47:1457-64
29. Ovsyannikova IG, Poland GA. 2011. Vaccinomics: current findings, challenges and novel approaches for vaccine development. AAPS J. 13:438-44
30. Poland GA, Kennedy RB, McKinney BA, Ovsyannikova IG, Lambert ND, et al. 2013. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin. Immunol. 25:89-103
31. Zentner GE, Henikoff S. 2014. High-resolution digital profiling of the epigenome. Nat. Rev. Genet. 15:814-27
32. Flanagan JM. 2015. Epigenome-wide association studies (EWAS): past, present, and future. Methods Mol. Biol. 1238:51-63
33. Martin P, McGovern A, Orozco G, Duffus K, Yarwood A, et al. 2015. Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci. Nat. Commun. 6:10069
34. Bellamy R, Ruwende C, Corrah T, McAdam K P, Whittle HC, Hill AV. 1998. Variations in theNRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338:640-44
35. McLaren PJ, Carrington M. 2015. The impact of host genetic variation on infection with HIV-1. Nat. Immunol. 16:577-83
36. Carvalho A, Cunha C, Pasqualotto AC, Pitzurra L, Denning DW, Romani L. 2010. Genetic variability of innate immunity impacts human susceptibility to fungal diseases. Int. J. Infect. Dis. 14:e460-8
37. Ciancanelli MJ, Abel L, Zhang SY, Casanova JL. 2016. Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr. Opin. Immunol. 38:109-20
38. Alcais A, Abel L, Casanova JL. 2009. Human genetics of infectious diseases: between proof of principle and paradigm. J. Clin. Investig. 119:2506-14
39. Driss A, Hibbert JM, Wilson NO, Iqbal SA, Adamkiewicz TV, Stiles JK. 2011. Genetic polymorphisms linked to susceptibility to malaria. Malar. J. 10:271
40. Timmann C, Thye T, Vens M, Evans J, May J, et al. 2012. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature 489:443-46
41. Band G, Le QS, Jostins L, Pirinen M, Kivinen K, et al. 2013. Imputation-based meta-analysis of severe malaria in three African populations. PLOS Genet. 9:e1003509
42. Rockett KA, Clarke GM, Fitzpatrick K, Hubbart C, Jeffreys AE, et al.; for Malar. Genom. Epidemiol. Netw. 2014. Reappraisal of known malaria resistance loci in a large multicenter study. Nat. Genet. 46:1197-204
43. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, et al. 2009. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet. 41:657-65
44. Malaria Genom. Epidemiol. Netw. 2015. A novel locus of resistance to severe malaria in a region of ancient balancing selection. Nature 526:253-57
45. Teo YY, Small KS, Kwiatkowski DP. 2010. Methodological challenges of genome-wide association analysis in Africa. Nat. Rev. Genet. 11:149-60
46. Mu J, Myers RA, Jiang H, Liu S, Ricklefs S, et al. 2010. Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat. Genet. 42:268-71
47. Monot M, Honore N, Garnier T, Zidane N, Sherafi D, et al. 2009. Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat. Genet. 41:1282-89
48. Mira MT, Alcais A, Van Thuc N, Thai VH, Huong NT, et al. 2003. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat. Genet. 33:412-15
49. Mira MT, Alcais A, Nguyen VT, Moraes MO, Di Flumeri C, et al. 2004. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427:636-40
50. Davila S, Wright VJ, Khor CC, Sim KS, Binder A, et al. 2010. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat. Genet. 42:772-76
51. Zhang F, Liu H, Chen S, Low H, Sun L, et al. 2011. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat. Genet. 43:1247-51
52. Schurr E, Gros P. 2009. A common genetic fingerprint in leprosy and Crohn's disease? N. Engl. J. Med. 361:2666-68
53. Liu H, Irwanto A, Tian H, Fu X, Yu Y, et al. 2012. Identification of IL18RAP/IL18R1 and IL12B as leprosy risk genes demonstrates shared pathogenesis between inflammation and infectious diseases. Am. J. Hum. Genet. 91:935-41
54. Liu H, Irwanto A, Fu X, Yu G, Yu Y, et al. 2015. Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy. Nat. Genet. 47:267-71
55. Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, et al. 2010. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat. Genet. 42:739-41
56. Dai Y, Zhang X, Pan H, Tang S, Shen H, Wang J. 2011. Fine mapping of genetic polymorphisms of pulmonary tuberculosis within chromosome 18q11.2 in the Chinese population: a case-control study. BMC Infect. Dis. 11:282
57. Thye T, Owusu-Dabo E, Vannberg FO, van Crevel R, Curtis J, et al. 2012. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat. Genet. 44:257-59
58. Curtis J, Luo Y, Zenner HL, Cuchet-Lourenco D, Wu C, et al. 2015. Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration. Nat. Genet. 47:523-27
59. Abel L, El-Baghdadi J, Bousfiha AA, Casanova JL, Schurr E. 2014. Human genetics of tuberculosis: a long and winding road. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 369:20130428
60. Lewis LA, Ram S. 2014. Meningococcal disease and the complement system. Virulence 5:98-126
61. Ko DC, Urban TJ. 2013. Understanding human variation in infectious disease susceptibility through clinical and cellular GWAS. PLOS Pathog. 9:e1003424
62. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401
63. Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, et al. 2013. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann. Intern. Med. 158:235-45
64. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-801
65. Bibert S, Roger T, Calandra T, Bochud M, Cerny A, et al. 2013. IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. J. Exp. Med. 210:1109-16
66. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, et al. 2008. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40:1461-65
67. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, et al. 2010. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patientswith nonalcoholic fatty liver disease. Hepatology 51:1209-17
68. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, et al. 2009. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 41:591-95
69. Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, et al. 2011. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet. 20:3884-92
70. Hu Z, Liu Y, Zhai X, Dai J, Jin G, et al. 2013. New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat. Genet. 45:1499-503
71. Limou S, Coulonges C, Herbeck JT, van Manen D, An P, et al. 2010. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J. Infect. Dis. 202:908-15
72. McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, et al. 2015. Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. PNAS 112:14658-63
73. Haralambieva IH, Ovsyannikova IG, Dhiman N, Kennedy RB, O'Byrne M, et al. 2011. Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans. J. Infect. Dis. 204:433-41
74. Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, Poland GA. 2012. Genomewide association study of antibody response to smallpox vaccine. Vaccine 30:4182-89
75. Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, et al. 2012. Genome-wide genetic associations with IFNγresponse to smallpox vaccine. Hum. Genet. 131:1433-51
76. Kennedy RB, Ovsyannikova IG, Pankratz VS, Haralambieva IH, Vierkant RA, Poland GA. 2012. Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum. Genet. 131:1403-21
77. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, et al. 2006. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24:341-48
78. Reefer AJ, Satinover SM, Solga MD, Lannigan JA, Nguyen JT, et al. 2008. Analysis of CD25hiCD4+ "regulatory" T-cell subtypes in atopic dermatitis reveals a novel TH2-like population. J. Allergy Clin. Immunol. 121:415-22.e3
79. Kennedy RB, Ovsyannikova IG, Haralambieva IH, Lambert ND, Pankratz VS, Poland GA. 2014. Genome-wide SNP associations with rubella-specific cytokine responses inmeasles-mumps-rubella vaccine recipients. Immunogenetics 66:493-99
80. Feenstra B, Pasternak B, Geller F, Carstensen L, Wang T, et al. 2014. Common variants associated with general and MMR vaccine-related febrile seizures. Nat. Genet. 46:1274-82
81. Haralambieva IH, Kennedy RB, Ovsyannikova IG, Whitaker JA, Poland GA. 2015. Variability in humoral immunity to measles vaccine: new developments. Trends Mol. Med. 21:789-801
82. Dhiman N, Poland GA, Cunningham JM, Jacobson RM, Ovsyannikova IG, et al. 2007. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J. Allergy Clin. Immunol. 120:666-72
83. Clifford HD, Hayden CM, Khoo SK, Naniche D, Mandomando IM, et al. 2012. Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique. Vaccine 30:6180-85
84. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, et al. 2013. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J. Clin. Immunol. 33:1078-87
85. Parvaneh N, Quartier P, Rostami P, Casanova JL, de Lonlay P. 2014. Inborn errors of metabolism underlying primary immunodeficiencies. J. Clin. Immunol. 34:753-71
86. Casanova JL, Conley ME, Seligman SJ, Abel L, Notarangelo LD. 2014. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J. Exp. Med. 211:2137-49
87. Boisson B, Quartier P, Casanova JL. 2015. Immunological loss-of-function due to genetic gain-offunction in humans: autosomal dominance of the third kind. Curr. Opin. Immunol. 32:90-105
88. Anderson MS, Casanova JL. 2015. More than meets the eye: monogenic autoimmunity strikes again. Immunity 42:986-88
89. Fischer A, Le Deist F, Hacein-Bey-Abina S, Andre-Schmutz I, de Saint Basile G, et al. 2005. Severe combined immunodeficiency: a model disease for molecular immunology and therapy. Immunol. Rev. 203:98-109
90. Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. 2014. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front. Immunol. 5:162
91. Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. 2011. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin. Mol. Allergy 9:10
92. Trapani V, Shomer N, Rajcan-Separovic E. 2015. The role of MAGT1 in genetic syndromes. Magnes. Res. 28:46-55
93. Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, et al. 2011. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365:127-38
94. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-27
95. Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, et al. 2008. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol. Rev. 226:29-40
96. Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL. 2012. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr. Opin. Allergy Clin. Immunol. 12:616-22
97. Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. 2014. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin. Immunol. 26:454-70
98. Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, et al. 2001. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293:300-3
99. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, et al. 2011. Gain-of-function human STAT1mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208:1635-48
100. Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, et al. 2001. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat. Genet. 27:313-17
101. Salem S, Langlais D, Lefebvre F, Bourque G, Bigley V, et al. 2014. Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation. Blood 124:1894-904
102. Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, et al. 2011. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43:1012-17
103. Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, et al. 2011. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118:2653-55
104. Dickinson RE, Griffin H, Bigley V, Reynard LN, Hussain R, et al. 2011. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118:2656-58
105. Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, et al. 2006. Human tyrosine kinase 2 deficiency reveals its requisite roles inmultiple cytokine signals involved in innate and acquired immunity. Immunity 25:745-55
106. Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ramirez-Alejo N, et al. 2015. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J. Exp. Med. 212:1641-62
107. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. PNAS 106:9362-67
108. Li MJ, Wang P, Liu X, Lim EL, Wang Z, et al. 2012. GWASdb: a database for human genetic variants identified by genome-wide association studies. Nucleic Acids Res. 40:D1047-54
109. Webb AJ, Thorisson GA, Brookes AJ, Consortium GP. 2011. An informatics project and online "Knowledge Centre" supporting modern genotype-to-phenotype research. Hum. Mutat. 32:543-50
110. Thorisson GA, Lancaster O, Free RC, Hastings RK, Sarmah P, et al. 2009. HGVbaseG2P: a central genetic association database. Nucleic Acids Res. 37:D797-802
111. Cortes A, Brown MA. 2011. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13:101
112. SiddleKJ, Quintana-Murci L. 2014. TheRed Queen's long race: human adaptation to pathogen pressure. Curr. Opin. Genet. Dev. 29:31-38
113. Lenardo M, Lo B, Lucas CL. 2016. Genomics of immune diseases and new therapies. Annu. Rev. Immunol. 34:121-49
114. Steinman L. 2009. A molecular trio in relapse and remission in multiple sclerosis. Nat. Rev. Immunol. 9:440-47
115. Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5:629-40
116. Benson RA, McInnes IB, Brewer JM, Garside P. 2015. Cellular imaging in rheumatic diseases. Nat. Rev. Rheumatol. 11:357-67
117. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9:679-91
118. Bianco AM, Girardelli M, Tommasini A. 2015. Genetics of inflammatory bowel disease from multifactorial to monogenic forms. World J. Gastroenterol. 21:12296-310
119. Salzer E, Kansu A, Sic H, Majek P, Ikinciogullari A, et al. 2014. Early-onset inflammatory bowel disease and commonvariable immunodeficiency-like disease caused by IL-21 deficiency. J. Allergy Clin. Immunol. 133:1651-59.e12
120. Glocker EO, Frede N, Perro M, Sebire N, Elawad M, et al. 2010. Infant colitis-it's in the genes. Lancet 376:1272
121. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, et al. 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361:2033-45
122. Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, et al. 2012. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 143:347-55
123. Romberg N, Al Moussawi K, Nelson-Williams C, Stiegler AL, Loring E, et al. 2014. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat. Genet. 46:1135-39
124. Borte S, Celiksoy MH, Menzel V, Ozkaya O, Ozen FZ, et al. 2014. Novel NLRP12 mutations associated with intestinal amyloidosis in a patient diagnosed with common variable immunodeficiency. Clin. Immunol. 154:105-11
125. Blaydon DC, Biancheri P, Di WL, Plagnol V, Cabral RM, et al. 2011. Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med. 365:1502-8
126. Cheng LE, Kanwar B, Tcheurekdjian H, Grenert JP, Muskat M, et al. 2009. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin. Immunol. 132:124-31
127. Mizukami T, Obara M, Nishikomori R, Kawai T, Tahara Y, et al. 2012. Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J. Clin. Immunol. 32:39-49
128. Aguilar C, Lenoir C, Lambert N, Begue B, Brousse N, et al. 2014. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J. Allergy Clin. Immunol. 134:1131-41.e9
129. Dziadzio M, Ammann S, Canning C, Boyle F, Hassan A, et al. 2015. Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency. J. Clin. Immunol. 35:439-44
130. Yang X, Kanegane H, Nishida N, Imamura T, Hamamoto K, et al. 2012. Clinical and genetic characteristics of XIAP deficiency in Japan. J. Clin. Immunol. 32:411-20
131. Zeissig Y, Petersen BS, Milutinovic S, Bosse E, Mayr G, et al. 2015. XIAP variants in male Crohn's disease. Gut 64:66-76
132. Conley ME, Dobbs AK, Quintana AM, Bosompem A, Wang YD, et al. 2012. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85asubunit of PI3K. J. Exp. Med. 209:463-70
133. Avitzur Y, Guo C, Mastropaolo LA, Bahrami E, Chen H, et al. 2014. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 146:1028-39
134. Chen R, Giliani S, Lanzi G, Mias GI, Lonardi S, et al. 2013. Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias. J. Allergy Clin. Immunol. 132:656-64.e17
135. Okou DT, Mondal K, Faubion WA, Kobrynski LJ, Denson LA, et al. 2014. Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 58:561-68
136. Dhillon SS, Fattouh R, Elkadri A, Xu W, Murchie R, et al. 2014. Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. Gastroenterology 147:680-89.e2
137. Zhou Q, Lee GS, Brady J, Datta S, Katan M, et al. 2012. A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am. J. Hum. Genet. 91:713-20
138. Zeissig S, Petersen BS, Tomczak M, Melum E, Huc-Claustre E, et al. 2015. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4. Gut 64:1889-97
139. Liang L, Morar N, Dixon AL, Lathrop GM, Abecasis GR, et al. 2013. A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res. 23:716-26
140. Langlais D, Barreiro LB, Gros P. 2016. Themacrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation. J. Exp. Med. 213:585-603
141. Fehr T, Schoedon G, Odermatt B, Holtschke T, Schneemann M, et al. 1997. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J. Exp. Med. 185:921-31
142. Marquis JF, LaCourse R, Ryan L, North RJ, Gros P. 2009. Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8. J. Immunol. 182:3008-15
143. Berghout J, Langlais D, Radovanovic I, Tam M, MacMicking JD, et al. 2013. Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. PLOS Pathog. 9:e1003491
144. Fairfax BP, Humburg P, Makino S, Naranbhai V, Wong D, et al. 2014. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343:1246949
145. Kennedy JM, Fodil N, Torre S, Bongfen SE, Olivier JF, et al. 2014. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation. J. Exp. Med. 211:2519-35
146. Radovanovic I, Leung V, Iliescu A, Bongfen SE, Mullick A, et al. 2014. Genetic control of susceptibility to Candida albicans in SM/J mice. J. Immunol. 193:1290-300
147. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, et al. 2010. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466:113-17
148. Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, et al. 2012. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum. Mol. Genet. 21:5209-21
149. Fischer A, Schmid B, Ellinghaus D, Nothnagel M, Gaede KI, et al. 2012. A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1. Am. J. Respir. Crit. Care Med. 186:877-85
150. Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, et al. 2012. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat. Genet. 44:676-80
151. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, et al. 2007. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39:857-64
152. Ferreira RC, Pan-Hammarstrom Q, Graham RR, Gateva V, Fontan G, et al. 2010. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat. Genet. 42:777-80
153. Sutherland A, Davies J, Owen CJ, Vaikkakara S, Walker C, et al. 2007. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J. Clin. Endocrinol. Metab. 92:3338-41
154. Genet. Anal. Psoriasis Consort.,Wellcome Trust Case Control Consort. 2010. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42:985-90
155. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324:387-89
156. Cen H, Wang W, Leng RX, Wang TY, Pan HF, et al. 2013. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Autoimmunity 46:455-62
157. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, et al. 2009. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41:1228-33
158. Molineros JE, Maiti AK, Sun C, Looger LL, Han S, et al. 2013. Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLOS Genet. 9:e1003222
159. Funabiki M, Kato H, Miyachi Y, Toki H, Motegi H, et al. 2014. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 40:199-212
160. Rice GI, del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, et al. 2014. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 46:503-9
161. Oda H, Nakagawa K, Abe J, Awaya T, Funabiki M, et al. 2014. Aicardi-Goutieres syndrome is caused by IFIH1 mutations. Am. J. Hum. Genet. 95:121-25
162. Gazzinelli RT, Kalantari P, Fitzgerald KA, Golenbock DT. 2014. Innate sensing of malaria parasites. Nat. Rev. Immunol. 14:744-57
163. Crompton PD, Moebius J, Portugal S, Waisberg M, Hart G, et al. 2014. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu. Rev. Immunol. 32:157-87
164. Lastoria JC, Abreu MA. 2014. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects-Part 1. Bras. Dermatol. 89:205-18
165. Eichelmann K, Gonzalez Gonzalez SE, Salas-Alanis JC, Ocampo-Candiani J. 2013. Leprosy: an update; definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr. 104:554-63
166. Tebruegge M, Curtis N. 2008. Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin. Microbiol. Rev. 21:519-37
167. Kim KS. 2003. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. 4:376-85
168. Moir S, Chun TW, Fauci AS. 2011. Pathogenic mechanisms of HIV disease. Annu. Rev. Pathol. 6:223-48
169. Maartens G, Celum C, Lewin SR. 2014. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet 384:258-71
170. St John AL, Abraham SN, Gubler DJ. 2013. Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nat. Rev. Microbiol. 11:420-26
171. de Souza HS, Fiocchi C. 2016. Immunopathogenesis of IBD: current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13:13-27
172. Liu TC, Stappenbeck TS. 2016. Genetics and pathogenesis of inflammatory bowel disease. Annu. Rev. Pathol. 11:127-48
173. Abadie V, Sollid LM, Barreiro LB, Jabri B. 2011. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu. Rev. Immunol. 29:493-525
174. Dendrou CA, Fugger L, Friese MA. 2015. Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 15:545-58
175. Ontaneda D, Hyland M, Cohen JA. 2012. Multiple sclerosis: new insights in pathogenesis and novel therapeutics. Annu. Rev. Med. 63:389-404
176. Picerno V, Ferro F, Adinolfi A, Valentini E, Tani C, Alunno A. 2015. One year in review: the pathogenesis of rheumatoid arthritis. Clin. Exp. Rheumatol. 33:551-58
177. McInnes IB, Buckley CD, Isaacs JD. 2016. Cytokines in rheumatoid arthritis-shaping the immunological landscape. Nat. Rev. Rheumatol. 12:63-68
178. LowesMA, Bowcock AM, Krueger JG. 2007. Pathogenesis and therapy of psoriasis. Nature 445:866-73